
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
POLICY AND PRACTICE REVIEWS article
Front. Public Health
Sec. Public Health Policy
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1453470
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Rationale: Leprosy remains a significant public health problem in Indonesia, with 14,000-15,000 new cases reported each year, indicating ongoing transmission. In response to the challenges, the country needs a strategic approach to achieve zero leprosy by 2030 through creating a national action plan.Objective: To describe the development of a national action plan for leprosy in Indonesia, its strategies, and key interventions.Methods: The process of NAP-L development consisted of three phases: (1) the preparatory phase involving 78 participants in five online group discussions (OGD) and document reviews to gain an understanding of the current situation of leprosy control; (2) the implementation phase, involving eight workshops with representatives from 14 provincial health offices, six district health offices, and 78 stakeholders to discuss stakeholder mapping and key components in the national action plan; and (3) the finalization phase to produce the complete document. All workshops and OGDs were audio-recorded. Verbatim transcripts were produced from the OGDs, and a thematic qualitative analysis was carried out to identify codes and categories of barriers to leprosy control. Each workshop's summary was documented. Results: Barriers to leprosy control were categorized into program inputs, implementation barriers from demand and supply perspectives, and proposed improvements. Four innovative strategies were formulated. The strategies were: (i) mobilizing various community resources (community); (ii) increasing the capacity of the healthcare system in the prevention, early detection, diagnosis, and management of leprosy in a comprehensive and quality manner (acceleration); (iii) improving integration and coordination with stakeholders and public-private healthcare providers (integration); and (iv) strengthening commitment, policy, and leprosy program management (commitment, policy, and management). Twenty-one key interventions and three measurable outcomes were proposed.Conclusions: The national action plan for leprosy control was developed through a participatory process involving multiple stakeholders from health and cross-sectors, public and private sectors, healthcare providers, community leaders, and persons affected by leprosy. To ensure successful implementation, a national monitoring and evaluation framework should be established to keep track of the progress and local governments should adopt the national action plan into their local health policies.
Keywords: Zero leprosy, National Action Plan, leprosy elimination, strategy, public health policy, Disease, Indonesia, Neglected tropical disease
Received: 23 Jun 2024; Accepted: 27 Mar 2025.
Copyright: © 2025 Sebong, Ferdiana, Tegu, Harbianto, Soviandhi, Sinaga, Budiawan, Risnanto, Sidjabat, Yudopuspito, Mawardi, Setyawati and Utarini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Adi Utarini, Department of Health Policy and Management, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.